GlassScriptPhysician profile
Amanda Lea Bierman
NPI 1316108939
$1,015.35
in general payments reported to CMS, 2019-2025
19 companies · $452 in 2025
The $452 reported for 2025 was more than what 92% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $15.47 · 2022: $38.37 · 2023: $21.16 · 2024: $325 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $798.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $170.98 | 2019-2025 | Tavneos |
| Glaxosmithkline, LLC. | $157.67 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Novo Nordisk INC | $121.34 | 2019-2025 | Wegovy |
| Merck Sharp & Dohme LLC | $85.47 | 2024-2025 | Vaxneuvance, Capvaxive, Enflonsia |
| Otsuka America Pharmaceutical, INC. | $75.84 | 2024-2025 | Voyxact, Jynarque, Rexulti |
| Sanofi Pasteur INC. | $73.04 | 2022-2025 | |
| Ironshore Pharmaceuticals INC. | $55.75 | 2023-2024 | Jornay Pm |
| Ge Healthcare | $35.67 | 2019 | |
| Phathom Pharmaceuticals, INC. | $31.92 | 2024 | Voquezna |
| Pfizer INC. | $29.67 | 2019-2024 | |
| Supernus Pharmaceuticals, INC. | $29.30 | 2025 | Qelbree |
| Seqirus USA INC | $29.15 | 2024 | Flucelvax, Fluad |
| Abbvie INC. | $24.26 | 2025 | |
| Acadia Pharmaceuticals INC | $19.19 | 2024 | Daybue |
| Sobi, INC | $18.19 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $17.33 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.65 | 2024 | Xifaxan |
| Paratek Pharmaceuticals, INC. | $14.19 | 2024 | Nuzyra |
| Medtronic Minimed, INC. | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Bierman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.